BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ignite II - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://gmkb.org
X-WR-CALDESC:Events for Ignite II
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240317
DTSTAMP:20260425T150906
CREATED:20231231T050844Z
LAST-MODIFIED:20231231T050844Z
UID:3804-1710201600-1710633599@gmkb.org
SUMMARY:2024 ACMG Annual Clinical Genetics Meeting
DESCRIPTION:2024 ACMG Annual Clinical Genetics Meeting \nMarch 12-16 | Toronto\, Canada \nThe ACMG sponsors an Annual Clinical Genetics Meeting and other events offering educational content in clinical genetics with the purpose of serving its members\, other healthcare professionals and the public. Experience the transformation of medical genetics as treatments can increasingly be tailored with precision medicine and therapeutics. \nTo learn more and register\, visit the meeting website. \nPlease note: Registration is required for in-person attendance and does not include session recordings. ACMG’s Digital Edition for recordings can be purchased separately and will be made available after the conference.
URL:https://gmkb.org/event/2024-acmg-annual-clinical-genetics-meeting/
LOCATION:Metro Toronto Convention Center\, 255 Front St W\, Toronto\, Ontario\, M5V 2W6\, Canada
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240322T120000
DTEND;TZID=America/New_York:20240322T130000
DTSTAMP:20260425T150906
CREATED:20240229T215532Z
LAST-MODIFIED:20240229T215532Z
UID:3902-1711108800-1711112400@gmkb.org
SUMMARY:Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
DESCRIPTION:Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative \nFriday\, March 22 | 12 p.m. ET | Hybrid: 321 MacNider Hall & Virtual \nSpeaker: Vardit Ravitsky\, PhD\nPresident and CEO\, The Hastings Center\nSenior Lecturer on Global Health and Social Medicine\, Harvard Medical School\nProfessor\, University of Montréal \nDr. Ravitsky will be speaking at the UNC Center for Bioethics’ Research Ethics Grand Rounds Merrimon Lecture. She is the President and CEO of The Hastings Center\, an independent\, nonpartisan bioethics research institute that is among the most prestigious bioethics and health policy institutes in the world. Dr. Ravitsky joins the Center from the University of Montreal where she was Professor at the Bioethics Program\, School of Public Health. She is also a Senior Lecturer on Global Health and Social Medicine at Harvard Medical School. She received her PhD from Bar-Ilan University in Israel\, her MA from the University of New Mexico\, and her BA from the Sorbonne University in Paris\, France. Dr. Ravitsky runs an active research program and holds several positions on advisory boards. Her research in bioethics focuses on ethical\, legal\, and social implications of genomics and assisted reproductive technologies\, with an emphasis on emerging biotechnologies and their implications for women’s autonomy and for disability rights. She also studies the ethics of AI in biomedicine. \nTo learn more\, visit the event webpage. \nZoom Webinar Link | Passcode: 004091
URL:https://gmkb.org/event/ethical-aspects-of-ai-in-biomedical-research-the-nih-bridge-to-ai-initiative/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20260425T150906
CREATED:20231231T202746Z
LAST-MODIFIED:20231231T202746Z
UID:3807-1711411200-1711670399@gmkb.org
SUMMARY:2024 Precision Medicine Tri-Conference
DESCRIPTION:2024 Precision Medicine Tri-Conference \nMarch 26-28 | San Diego\, CA \nJoin thousands of international thought leaders to discuss the latest research\, technologies\, innovation and business models in precision medicine and precision health. Topics will include innovation and market access strategies for at-home diagnostics\, liquid biopsy and advanced diagnostics for precision oncology\, AI and digital tools\, spatial biology and single-cell multiomics in advancing precision medicine and more. \nTo learn more and register\, visit the conference website. \nPlease note: Registration is required for both in-person and virtual attendees.
URL:https://gmkb.org/event/2024-precision-medicine-tri-conference/
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240326T120000
DTEND;TZID=America/New_York:20240326T130000
DTSTAMP:20260425T150906
CREATED:20240302T032504Z
LAST-MODIFIED:20240302T032504Z
UID:3904-1711454400-1711458000@gmkb.org
SUMMARY:Carolina Seminar Series | Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine
DESCRIPTION:Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine \nTuesday\, March 26 | 12 p.m. ET | Virtual \nSpeaker: Kate Saylor\, PhD\nFellow\, Ethical\, Legal\, and Social Implications (ELSI) of Genetics and Genomics\,\nPerelman School of Medicine at the University of Pennsylvania \nEfforts to expand access to genomic health and precision medicine have resulted in a proliferation of screening programs for healthy adult populations across the nation. Issues of fairness and equity abound in medicine and are a critical component of assessing implementation of these genomic health and precision medicine efforts. But how can programs such as genomic screening ensure equitable access within a healthcare system that is already characterized by massive health disparities and barriers to equitable access? When and how should cost-effectiveness be considered when designing screening programs and their offerings? How can cost-effectiveness models incorporate justice\, equity and inclusion? In this seminar session\, we will explore these questions and the overall relationship between equity and economic considerations in precision medicine. \nTo learn more and register\, visit the event webpage.
URL:https://gmkb.org/event/carolina-seminar-series-ensuring-fairness-at-the-crossroads-of-equity-and-economic-considerations-in-precision-medicine/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240328T090000
DTEND;TZID=America/New_York:20240328T100000
DTSTAMP:20260425T150906
CREATED:20240323T034101Z
LAST-MODIFIED:20240323T034101Z
UID:3911-1711616400-1711620000@gmkb.org
SUMMARY:The All of Us Research Program
DESCRIPTION:The All of Us Research Program \nThursday\, March 28 | 9 a.m. ET | Online \nSpeaker: Geoffrey Ginsburg\, MD\, PhD \nDr. Geoffrey Ginsburg is the chief medical and scientific officer of the National Institute of Health (NIH)’s All of Us Research Program\, where he leads the scientific vision and strategy for the program. Previously\, he was founding director of the Center for Applied Genomics & Precision Medicine at Duke University School of Medicine and held senior leadership roles at Millennium Pharmaceuticals Inc. He has influenced precision medicine in the U.S. and internationally\, serving as co-chair of the National Academies’ Roundtable on Genomic and Precision Health\, a founding co-chair of the International HundredK+ Cohorts Consortium\, and founder and president of the Global Genomic Medicine Collaborative (G2MC). \nThis talk will cover the All of Us Research Program—a historic effort to gather data from 1 million or more people in the U.S. to accelerate research and improve health\, with a focus on engaging communities historically underrepresented in biomedical research. Since national launch in 2018\, less than 750\,000 participants have enrolled. Diverse participant partners (about 80% from underrepresented backgrounds including racial/ethnic minority groups\, gender minority groups\, disability status\, access to healthcare\, etc.) are sharing health-related data and biospecimens. All of Us data are housed in the cloud-based Researcher Workbench\, which includes tools\, support resources\, sample data workbooks and more. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar.
URL:https://gmkb.org/event/the-all-of-us-research-program/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR